Enfermedad de Parkinson: fisiopatología y nuevos tratamientos
Wellcome Trust Sanger Institute
Cambridge, Reino UnidoPublications in collaboration with researchers from Wellcome Trust Sanger Institute (1)
2016
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Science Translational Medicine, Vol. 8, Núm. 341